Sudan Loganathan
Stock Analyst at Stephens & Co.
(0)
# 4701
Out of 5,270 analysts
32
Total ratings
28.00%
Success rate
-19.57%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Catalyst Pharmaceuti... | Reiterates: Overweight | 33 33 | 22.68 | 45.5% | 2 | Feb 27, 2025 | |
ADC Therapeutics | Maintains: Overweight | 6 8 | 1.59 | 403.14% | 2 | Feb 24, 2025 | |
IDEAYA Biosciences | Reiterates: Overweight | 50 50 | 19.56 | 155.62% | 2 | Feb 14, 2025 | |
Exelixis | Reiterates: Equal-Weight | 29 29 | 38.67 | -25.01% | 4 | Feb 12, 2025 | |
Bicycle Therapeutics | Reiterates: Equal-Weight | 15 15 | 10.5 | 42.86% | 2 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 31 31 | 14.26 | 117.39% | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 60 60 | 30.05 | 99.67% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 140 140 | 90.28 | 55.07% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 0.48 | 941.67% | 2 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.07 | 367.29% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 4 | 2.42 | 65.29% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 16.51 | 233.13% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 9.02 | 232.59% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 1.14 | 1040.35% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 25 25 | 13.74 | 81.95% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 0.45 | 1011.11% | 2 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | 1.88 | 963.83% | 1 | May 14, 2024 |